Interleukin 8 expression regulates tumorigenicity and metastases in androgen-independent prostate cancer

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 2104-2119

  Inoue, Keiji ^a   Slaton, Joel W ^a   Eve, Beryl Y ^a   Kim, Sun Jin ^a   Perrotte, Paul ^a   Balbay, M Derya ^a   Yano, Seiji ^a   Bar Eli, Menashe ^a   Radinsky, Robert ^a   Pettaway, Curtis A ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; INTERLEUKIN 8;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MALE; METASTASIS; MITOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; TUMOR GROWTH;

ANDROGENS; ANIMALS; BLOTTING, NORTHERN; CHLORAMPHENICOL O-ACETYLTRANSFERASE; COLLAGENASES; ENDOTHELIAL GROWTH FACTORS; FIBROBLAST GROWTH FACTOR 2; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOCHEMISTRY; IN SITU HYBRIDIZATION; INTERLEUKIN-8; LYMPHATIC METASTASIS; LYMPHOKINES; MALE; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOVASCULARIZATION, PATHOLOGIC; PROMOTER REGIONS (GENETICS); PROSTATIC NEOPLASMS; RECOMBINANT FUSION PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRANSFECTION; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0034068320     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Greenlee, R. T., Murray, T., Bolden, S., and Wingo, P. A. Cancer statistics, 2000. CA Cancer J. Clin., 50; 7-33, 2000.
2. Thompson, I. M., and Zeidman, E. J. Current urological practice: routine urological examination and early detection of carcinoma of the prostate. J. Urol., 326-330, 1992.
3. Powell, I. J., Heilbrun, L., Littrup, P. L., Franklin, A., Parzuchowski, J., Gelfand, D., and Sakr, W. Outcome of African American men screened for prostate cancer: the Detroit Education and Early Detection Study. J. Urol., 158: 146-149, 1997.
4. Catalona, W. J., Smith, D. S., Ratliff, T. L., and Basler, J. W. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening [see comments]. J. Am. Med. Assoc., 270: 948-954, 1993.
5. Catalona, W. J., Richie, J. P., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., deKernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. Comparison of digital rectal examination and serum prostate specific antigen in the early detection of prostate cancer: results of a multicenter clinical trial of 6,630 men [see comments]. J. Urol., 151: 1283-1290, 1994.
6. Kreis, W. Current chemotherapy and future directions in research for the treatment of advanced hormone-refractory prostate cancer. Cancer Investig., 13: 296-312, 1995.
7. Crissman, J. D. Tumor-host interactions as prognostic factors in the histologic assessment of carcinomas. Pathol. Annu., 1: 29-52, 1986.
8. Dickson, R. B. Regulation of tumor-host interactions in breast cancer. J. Steroid Biochem. Mol. Biol., 41: 389-400, 1992.
9. Fidler, I. J. Origin and biology of cancer metastasis. Cytometry, 10: 673-680, 1989.
10. Fidler, I. J. Critical factors in the biology of human cancer metastasis: twenty-eighth G. H. A. Clowes memorial award lecture. Cancer Res., 50: 6130-6138, 1990.
11. Fidler, I. J. Critical determinants of melanoma metastasis. J. Investig. Dermatol. Symp. Proc., 1: 203-208, 1996.
12. Fidler, I. J., Kumar, R., Bielenberg, D. R., and Ellis, L. M. Molecular determinants of angiogenesis in cancer metastasis. Cancer J. Sci. Am., S58-S66, 1998.
13. Kumar, R., and Fidler, I. J. Angiogenic molecules and cancer metastasis. In Vivo, 12: 27-34, 1998.
14. Folkman, J. Tumor angiogenesis. Adv. Cancer Res., 43: 175-203, 1985.
15. Folkman, J. How is blood vessel growth regulated in normal and neoplastic tissue? G. H. A. Clowes memorial award lecture. Cancer Res., 46: 467-473, 1986.
16. Folkman, J. What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst., 82: 4-6, 1990.
17. Jackson, M. W., Bentel, J. M., and Tilley, W. D. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia [see comments]. J. Urol., 157: 2323-2328, 1997.
18. Ferrer, F. A., Miller, L. J., Andrawis, R. I., Kurtzman, S. H., Albertsen, P. C., Laudone, V. P., Kreutzer, D. L. Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells. Urology, 51: 161-167, 1998.
19. Nakamoto, T., Chang, C. S., Li, A. K., Chodak, G. W. Basic fibroblast growth factor in human prostate cancer cells. Cancer Res., 52: 571-577, 1992.
20. Cronauer, M. V., Hittmair, A., Eder, I. E., Hobisch, A., Culig, Z., Ramoner, R., Zhang, J., Bartsch, G., Reissigl, A., Radmayr. C., Thurnher, M., Klocker, H. Basic fibroblast growth factor levels in cancer cells and in sera of patients suffering from proliferative disorders of the prostate. Prostate, 31: 223-233, 1997.
21. Greene, G. F., Kitadai, Y., Pettaway, C. A., von Eschenbach, A., Bucana, C. D., Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
22. Veltri, R. W., Miller, M. C., Zhao, G., Ng, A., Marley, G. M., Wright, F. L., Jr., Vessella, F. L., Ralph, D. Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer. Urology, 53: 139-147, 1999.
23. Weidner, N., Carroll, P. R., Flax, J., Blumenfeld, W., Folkman, J. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am. J. Pathol., 143: 401-409, 1993.
24. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., Oppenheim, J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med., 167: 1883-1893, 1988.
25. Matsushima, K., Baldwin, E. T., Mukaida, N. Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines. Chem. Immunol., 51: 236-265, 1992.
26. Wang, J. M., Taraboletti, G., Matsushima, K., Van, D. J., Mantovani, A. Induction of haptotactic migration of melanoma cells by neutrophil activating protein/interleukin-8. Biochem. Biophys. Res. Commun., 169: 165-170, 1990.
27. Krueger, G., Jorgensen, C., Miller, C., Schroeder, J., Sticherling, M., Christopher, E. Effect of IL-8 on epidermal proliferation. J. Invest. Dermatol., 94: 545, 1990.
28. Kumar, R., Yoneda, J., Bucana, C. D., Fidler, I. J. Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int. J. Oncol., 12: 749-757, 1998.